Are These Marijuana Stocks Included In Your Winning Portfolio?

The market for legalized marijuana will grow by 64% between 2014 and 2015, cites State of Marijuana Markets, “Cannabis is one of the fastest-growing industries,” Steve Berg tells The Huffington Post, “domestically, we weren’t able to find any market that is growing as quickly.”

The legal marijuana industry will generate revenues of $21 billion by 2020 if its predictions about legalization prove true, Greenwave reported. The revenues would rise to $35 billion if marijuana was legalized on the federal level. Furthermore, Greenwave Advisors predicts that 12 states and the District of Columbia will legalize recreational marijuana and 35+ additional states could legalize medicinal marijuana by 2020.

So with so much growth projected over the next 5 years, investors have put aside their inhibitions that many have had during the early part of 2014 and now carving a section of their portfolios out for investment in cannabis. One such segment, which has garnered more attention from “safe” investors, has been that of biotech.

Companies like Insys Therapeutics and GW Pharma are focused more on the prescription uses of the drugs active ingredients as opposed to the more “over-the-counter” style products that launched the crazy in early 2014. In the small cap space, Oxis International through its subsidiary, Oxis Biotech, has been captivating penny stock traders over the last few weeks.Material announcements include the addition of two key members to the company’s scientific advisory board.

To read more, visit

Posted in: Investing

Comments are closed.